Literature DB >> 28490478

Mixed cryoglobulinemia: a diagnostic and therapeutic challenge.

Maria Túlio1, Liliana Carvalho1, Tiago Bana E Costa1, Cristina Chagas1.   

Abstract

Mixed cryoglobulinemia is frequently secondary to hepatitis C virus infection. Diagnosis and therapeutic management are challenging, depending on the spectrum and severity of manifestations, as well as on the presence of comorbidities. We describe a case of a 79-year-old woman with a non-cirrhotic hepatitis C virus infection presenting with weakness, arthralgias, purpuric rash with left leg ulcerative lesions, bilateral peripheral sensorimotor polyneuropathy, renal impairment and cardiac failure. The investigation was compatible with a severe type II mixed cryoglobulinemia with multisystemic involvement, including a low-grade B cell lymphoma and concomitant intestinal tuberculosis. Initial management with immunosuppressive therapy with glucocorticoids to control symptoms and simultaneous tuberculosis treatment was required. Unavailability of adequate antiviral treatment led to the need to control the severity of systemic manifestations with rituximab, before the effective aetiological treatment with sofosbuvir and ledipasvir was possible, allowing the definitive resolution of the disease. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Hepatitis C; Immunology; Liver disease

Mesh:

Substances:

Year:  2017        PMID: 28490478      PMCID: PMC5612266          DOI: 10.1136/bcr-2017-219768

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.

Authors:  Meghan E Sise; Allyson K Bloom; Jessica Wisocky; Ming V Lin; Jenna L Gustafson; Andrew L Lundquist; David Steele; Michael Thiim; Winfred W Williams; Nikroo Hashemi; Arthur Y Kim; Ravi Thadhani; Raymond T Chung
Journal:  Hepatology       Date:  2015-12-11       Impact factor: 17.425

Review 2.  Extrahepatic morbidity and mortality of chronic hepatitis C.

Authors:  Francesco Negro; Daniel Forton; Antonio Craxì; Mark S Sulkowski; Jordan J Feld; Michael P Manns
Journal:  Gastroenterology       Date:  2015-08-28       Impact factor: 22.682

Review 3.  Cryoglobulinemia Vasculitis.

Authors:  Patrice Cacoub; Cloe Comarmond; Fanny Domont; Léa Savey; David Saadoun
Journal:  Am J Med       Date:  2015-03-30       Impact factor: 4.965

Review 4.  Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.

Authors:  Franco Dammacco; Domenico Sansonno
Journal:  N Engl J Med       Date:  2013-09-12       Impact factor: 91.245

Review 5.  Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.

Authors:  C Ferri; P Cacoub; C Mazzaro; D Roccatello; P Scaini; M Sebastiani; A Tavoni; A L Zignego; S De Vita
Journal:  Autoimmun Rev       Date:  2011-07-24       Impact factor: 9.754

6.  Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.

Authors:  Neal J Schamberg; Gerond V Lake-Bakaar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

7.  Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.

Authors:  Laura Gragnani; Elisa Fognani; Alessia Piluso; Barbara Boldrini; Teresa Urraro; Alessio Fabbrizzi; Cristina Stasi; Jessica Ranieri; Monica Monti; Umberto Arena; Claudio Iannacone; Giacomo Laffi; Anna Linda Zignego
Journal:  Hepatology       Date:  2015-02-10       Impact factor: 17.425

Review 8.  Extrahepatic manifestations in chronic hepatitis C virus carriers.

Authors:  E Rosenthal; P Cacoub
Journal:  Lupus       Date:  2015-04       Impact factor: 2.911

9.  Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.

Authors:  Luca Quartuccio; Francesca Zuliani; Laura Corazza; Patrizia Scaini; Roberta Zani; Marco Lenzi; Antonio Tavoni; Marco Sebastiani; Simone Baldovino; Teresa Urraro; Francesco Saccardo; Costanza Sbreglia; Cesare Mazzaro; Piero Pioltelli; Paolo Fraticelli; Davide Filippini; Armando Gabrielli; Oreste Perrella; Salvatore Scarpato; Dario Roccatello; Anna Linda Zignego; Clodoveo Ferri; Stefano Bombardieri; Maurizio Pietrogrande; Giuseppe Monti; Massimo Galli; Salvatore De Vita
Journal:  J Autoimmun       Date:  2015-08-05       Impact factor: 7.094

Review 10.  HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies.

Authors:  C Ferri; D Giuggioli; M Cazzato; M Sebastiani; M T Mascia; A L Zignego
Journal:  Clin Exp Rheumatol       Date:  2003 Nov-Dec       Impact factor: 4.473

View more
  1 in total

1.  Clinical Characteristics of Cryoglobulinemia With Cardiac Involvement in a Single Center.

Authors:  Kun He; Yun Zhang; Wei Wang; Yu Wang; Yue Sha; Xuejun Zeng
Journal:  Front Cardiovasc Med       Date:  2022-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.